CXCL5 drives obesity to diabetes, and further.: CXCL5 and metabolism

Abstract : We have recently shown that the CXCL5 chemokine is secreted by adipose tissue in the obese state. We demonstrated that adipose tissue-derived CXCL5 mediates insulin resistance in muscle. We speculate in this paper that CXCL5 could also mediate other obesity, and diabetes-derived pathologies, such as cardiovascular disease, retinopathy, or inflammatory bowel disease. In this scenario CXCL5 targeted therapy would prevent not only the development of type II diabetes in obese subjects, but also several other obesity-related co morbidities. Finally we propose to analyze the CXCL5 gene to find particular polymorphisms that could predict the development of type II diabetes in obese subjects.
Type de document :
Article dans une revue
Aging (Albany NY), 2009, 1 (7), pp.674-7
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00469840
Contributeur : Yves Le Ster <>
Soumis le : vendredi 2 avril 2010 - 16:34:10
Dernière modification le : mercredi 3 octobre 2018 - 16:02:07
Document(s) archivé(s) le : mercredi 8 septembre 2010 - 17:04:08

Fichiers

schema.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-00469840, version 1
  • PUBMED : 20157549

Citation

Carine Chavey, Lluis Fajas. CXCL5 drives obesity to diabetes, and further.: CXCL5 and metabolism. Aging (Albany NY), 2009, 1 (7), pp.674-7. 〈inserm-00469840〉

Partager

Métriques

Consultations de la notice

196

Téléchargements de fichiers

326